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INTRODUCTION 
 
 
 Information about stroke reveal that even after detailed 
clinical history, physical examination and bio-chemical tests, 
available non-invasive techniques in the evaluation, 40% of 
patients with ischemic stroke (80% of all stroke victims) remain 
without clear identifiable cause.  (2002 heart and stroke statistical 
update, American Heart Association).  This group of patients was 
clubbed under a sub group called cryptogenic stroke.  Evaluation 
of these patients with semi invasive techniques like 
transesophageal echocardiography revealed a lot of information 
into the insight of the etiology of stroke with this back ground, we 
studied patients with stroke and the utility of transesophageal 
echocardiography in identifying the cause of ischemic stroke in the 
so called cryptogenic stroke. 
 
 
 
 
  
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
 
 
Efficacy of transesophageal echocardiography in 
cryptogenic ischemic stroke 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 
 
Transesophageal Echocardiography (TEE) : 
Definition : 
 Is a diagnostic test using an ultrasound device that is passed 
into the esophagus of the patient to create a clear image of the 
heart muscle and other parts of the heart.  A tube with a device 
called a transducer is passed down into the patient’s throat and into 
the esophagus.  The transducer directs ultrasound waves into the 
heart and the reflected round waves picked up by the transducer 
into an image of the heart. 
 
Technology : 
 First successful demonstration of the use of esophageal 
window for echocardiogram was reported in 1976 by frazin. 
 Single plan transesophageal imaging was introduced in 1990 
by Dimagno et al.  
 Double plan transesophageal Imaging in 1982 by Souquet et 
al. 
  
 
TRANSESOPHAGEAL ECHO CARDIOGRAPHY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
TRANSESOPHAGEAL ECHO CARDIOGRAPHY 
PROBE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Multiplan transesophageal Imaging in 1985 by Harui and 
souquet. 
 Multiplan system provides on infinite number of planes over 
a full 180 rotation of a single phased array transducer. 
 
Once intubated, the images are acquired at three levels.  
These are shown in figures.  These include transgastric views, 
Lower, and Mid esophageal views and upper Esohageal views.  
Some operators prefer to go into the stomach straight to obtain the 
transgastric views first where as some prefer to go from upper 
esophageal to lower levels.  At the end of acquiring images at 
these three levels, the transducer is rotated posteriorly to view the 
descending thoracic Aorta.  Three main controls are available in 
the TEE probe.  The probe can be rotated clockwise or counter 
clockwise to obtain either the views from right side or left heart.  
The rotatory controls have separate knobs for medial and lateral 
movement, anteflexion and retroflexion, and finally the array in 
Multiplane   TEE can be moved through 180 degrees by motorized 
or manual controls.    
  
 
 
STANDARD TEE VIEWING PLANES AND VIEWS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
LOWER AND MID ESOPHAGEAL LEVEL VIEWS OF LV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Zero degree plan is called as horizontal plane and four 
chamber views of both right and left heart are best obtained in this 
position.  At around 35 to 45.  Short axis views are obtained, 90 
plane is called as longitudinal plane.  At 135 long axis views are 
obtained.  180 plane is called as reverse horizontal plane and 
mirror image views of the horizontal plane are obtained. 
  
Indications for Transesophageal echocardiography 
TEE as a Diagnostic Tool 
1. Stroke (Diagnostic yield  > 50%) 
2. Atrial fibrillation 
3. Prosthetic valve dysfunction 
4. Infective endocarditis 
5. Aortic Dissection 
6. Evaluation of Native valve 
7. Cardiac Masses 
8. ICU patient with hemodynamic instability 
9. Congenital heart disease 
 
 TEE as a Procedural adjunct : 
 Adjunct to percutaneous procedures : 
1. Percutaneous Balloon Mitral valvuloplasty 
2. ASD and PFO closure 
3. Interventional procedures for congenital heart disease 
 
Adjunct to surgical procedures : 
1. Heart valve repair 
2. Congenital heart surgery 
3. Ascending Aortic dissection repair 
4. Intra operative assessment of LV function 
5. Pericardial window procedures 
6. Repair of Hypertrophic obstructive cardiomyopathy 
VIEWS : 
A    - Upper Esophageal views  25 – 30 cm 
B - Mid and lower esophageal views 30-35 cm 
  Four chamber 
  Mitral commissural 
  Two chamber 
   Long axis 
  Ascending Aorta LAX and SAX 
  Aortic valve SAX 
  RV inflow – outflow 
  Bicaval 
C - Trans Gastric views   35-40 cm 
  SAX mitral and PM level 
  Two chamber view 
  Long axis view 
  RV inflow view 
  Deep trans gastric : Apical 5 c 
D - Aortic view 
 
Modified from Otto  :  The clinical practice of Echocardiography  
2nd edition  2002. 
 The atrial septum is viewed from the longitudinal plane of 
90.  The foramen ovale the thinnest portion of the inter atrial 
septum is very well seen from this view.  Transesophageal 
echocardiography has become the gold standard in the evaluation 
 of the inter atrial septum  and pattern foramen ovale.  The flap 
(septum primum) closes against the septum (septum secondum) 
before second year of life.  In some patients the fusion is 
incomplete and the gap persists as Patent Foramen Ovale (PFO).  
This occurs in about 25% of general population.  Figure shows the 
inter atrial septum and the two components.  The PFOs may be 
small or large  Counter clockwise rotation of the transducer and 
viewing posteriorly brings descending Aorta into focus at 
horizontal plane of 0o.  At 135 long axis views can be obtained. 
 
Primary Indication of TEE : 
A -   Endocarditis : 
 1. High clinical suspicion 
 2. Clinical suspicion of abscess 
 3. Congestive cardiac failure 
 4. Prosthetic valve 
 5. Intracardiac device 
B -   Cardioembolic Source : 
 1. Atrial septal aneurysm 
  2. Aortic thrombus 
 3. Interatrial septal defect including patent foramen ovale. 
 4. Left atrial thrombus 
C  -  Aortic Dissection 
D  -  Preoperative valve assessment 
E  -  Exclusion of atrial thrombus before mitral ballon  
 valvuloplasty 
F  -  Prosthetic valve dysfunction 
G  -  Intraoperative application 
 
Secondary Indications of TEE : 
A  -   Endocarditis : 
 1. Low clinical suspicion 
 2. Prosthetic valve dysfunction 
 3. Native valve endocarditis without cardiac failure 
B  -  Congenital Heart failure 
C  -  Evaluation of ventricular function 
D  -  Cardiac source of embolus – LV thrombus suspected 
E  -  Evaluation of hypotensive patient 
 Advantage of TEE over TTE 
1. No obstruction to ultrasound by chest wall structures or by 
lung tissue 
2. Different imaging planes allow visualization of structures 
not seen from the precardium 
3. Improved signal to noise ratio allow defection of poor 
echo reflective structures 
4. Higher ultrasound frequencies, providing higher 
resolution and more detailed imaging. 
5. Reduced target range for pulsed Doppler and higher 
sensitivity of colour flow imaging when studying 
posterior cardiac structures. 
 
Contraindication : 
Absolute : 
1. Unco-operative or unwilling patient 
2. Esophageal structure, tumour or diverticulam 
3. Active upper GI bleed 
4. Perforated viscus (suspected or known) 
 Complication : 
Rare : 
 Sore throat, transient hypertension, hypotension, non 
sustained VT, hypoxia, blood tinged sputum. 
Extremely rare : 
 Esophageal perforation, severe laryngospaim, vocal cord 
paralysis, ventricular tachyarrhythmias, cardiac failure, 
Anaphylaxis. 
 
TEE related to our study : 
TEE in potent foramen Ovale (PFO) and Atrial septal Aneurysm 
(ASA) : 
 The membrane of the fossa ovalis may be quite redundant 
and mobile and can be sufficiently large that is called interatrial 
septal aneurysm.  Aneurysm of the atrial septum appears to 
involve the septum primum portion of the fossa ovalis exclusively.  
Both have implicated as a source of systemic embolus or atleast a 
site for paradoxical embolization during right to left shunting.  
Imaging of the nature and extent of these aneurysm and of PFO is 
 usually best performed between 45 and 90 with the probe tip 
rotated slightly rightward from the aortic valve. 
 
 Patent Foramen ovale is implicated as an important cause for 
various clinical syndromes.  The prevalence of ‘probe’ patent 
foramen ovale (ie. Size 0.2 cm -0.6 cm), as evident by autopsy 
series is 26% (range 17% - 35%) and the prevalence of ‘pencil’ 
patent foramen ovale (ie size 0.6cm – 1.0 cm) is 6%.  The foramen 
ovale has a pivotal role during embryonic fetal life.  PFO is an 
embryological remnant of fetal circulation.  It results from 
incomplete fusion of the flap valve of the foramen ovale with the 
septum secondum, a process that is usually complete by 2 years of 
age.  But after birth it remains as a cause for paradoxical 
embolism, stroke, TIA, migraine, platypnea orthodexia syndrome 
and decompression illness in divers. 
 
 The prevalence of PFO is 46% inpatients below 55 years of 
age with cryptogenic stroke.  The prevalence of PFO in young 
individuals with cryptogenic stroke is much higher than in the 
 elderly (21 % prevalence).  According to PICS study cryptogenic 
stroke contributes 42% of all ischemic strokes.  TEE was able to 
identify PFO in 39% of patients with cryptogenic stroke. 
 
 Decompression Sickness (DCS) results from formation of 
bubbles in body fluids as the ambient pressure is reduced.  The 
first cause of arterial Gas Embolism (AGE) was described in a 
scuba diver who had an ASD. Later TEE studies showed an 
association between PFO and DCS in divers.  Same way high 
altitude aviators and astronauts are prone to develop DCS. There is 
an increased prevalence of brain lesions in divers in the absence of 
recognized decompressive illness.  Transcranial Doppler 
ultrasonography can detect right to left shunt in almost all divers 
with multiple brain lesions.  This is most commonly due to PFO.  
Diving in the presence of PFO results in multiple brain lesions.  
Some of the diving schools recommend screening for PFO for 
professional divers or avid amateurs. 
 
  There is 2-5 fold increase in prevalence of migraine in PFO 
carriers.  This may be due to small brain embolisms or due to 
serotonin that has bypassed the lung metabolism because of the 
PFO.  Patients with PFO are at the risk of stroke if they undergo 
any major surgery.  So, high risk patients need to be screened for 
PFO before major surgical procedure to avoid potential 
paradoxical embolism and the resultant major cerebro vascular 
events.  Finally, Platypnea – orthodeoxia is a rare syndrome seen 
in the elderly.  The affected individual becomes cyanotic and 
dysponeic while sitting up and this disappears when the patient lye 
down.  A right to left shunt can be demonstrated even in PFO.  
The Eustachian valve may become prominent with aging.  This 
valve directs IVC blood towards PFO.  Associated  pulmonary 
hypertension can lead to continuous arterial desaturation.  PFO is 
commonly associated with Atrial Septal Aneursym ASA and 
Chiari Network which is due to incomplete resorption of septum 
spurium and the right valve of the sinus venosus.  The prevalence 
of ASA is 1% and of Chairi network is 2% - 3%.as evident by 
autopsy studies.  83% of patients with Chairi network have PFO. 
 Demonstration of PFO and ASA : 
 Trans throracic echocardiography, Trans esophageal 
echocardiography TEE, Native Tissue Harmonics (NTH) and 
Transcranial Doppler (TCD) are the commonly used test to 
identify right to left shunt.  TCD cannot identify the level of this 
shunt. PFO can be demonstrated by TTE in 8% by NTH in 19% 
and by TTE in 19% of general population.  Transesophagel 
echocardiography is the method of choice in demonstrating PFO. 
 
 This  test is best done by injecting aerated colloid / saline 
solution through a systemic peripheral vein, preferably in the 
femoral vein at the end of strain phase of valsalva maneuver.   
When the straining is discontinued, there is sudden gush of blood 
that enters the right atrium and distends the right atrium.  As 
because the left atrial chamber is still smaller for the initial 4-6 
cardiac cycles, the PFO is stretched and opened.  This results in 
transient right to left shunt at the atrial level.  This causes the 
contrast bubbles, which entere the RA to pass through the PFO 
into LA.  This test has excellent sensitivity. 
  Criteria for PFO detection includes finding of contrast in LA 
within three cardiac cycles after the RA opacification and the 
shunt is said to be significant if > 20 bubbles could be 
demonstrated in LA.  False negative TEE may result from 
inadequate visualization with in the esophagus, elevated LA 
pressure, IVC directed flow along the IAS preventing impingment 
of antecubital bubbles against the IAS or an improperly done 
valsalva maneuver.  The shunt across the PFO can be quantified as 
large if > 20 bubbles appear in LA and as small shunt if < 20 
bubbles appear in LA.  PFO can be demonstrated in 39% of 
patients with cryptogenic stroke and if Valsalva manure is also 
adopted PFO can be demonstrated in 50% of patients. 
 
 Demonstration of ASA is also important, as its presence with 
PFO is an important risk factor for cryptogenic stroke.  15% of 
patients with embolic stroke have ASA and 70% of these patients 
have associated PFO. But ASA is present in only 4% of the 
general population.  ASA is defined echocardiographically as base 
width > 14 mm with septal excursion > 10mm. 
  
 
 
VIEWING OF INTER ATRIAL SEPTUM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 PFO needs to be closed as it increases the risk of recurrent 
stroke by 5 fold.  The first percutaneous closure of PFO was done 
in 1989.  Various devices are available currently and all of them  
are equally good.  The procedural success rate is 90%  - 95%. The 
annual recurrence rate of stroke / TIA is 4%.  Patient needs 
antiplatelet therapy in the form of clopidogrel 75mg/day for one 
month and aspirin 325 mg/day for six months. 
  
TEE in Aortic Disease : 
 Atheromatous disease of the thoracic aorta has been sown to 
be a risk factor for systemic embolization.  Advent of TEE has 
permitted visualization of the thoracic aorta with details previously 
unavailable by TTE, including assessment of the intimal surface.  
Consequently the extent and morphology characteristic of 
atherosclerotic involvement of the thoracic aorta can be carefully 
studied particularly with Multiplan TEE karalis et al used TEE to 
defect atherosclerotic disease of the aorta and classified it as either 
 
  
 
VIEWING OF AORTA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Simple plaque, characterized by extension from the aorta 
wall into the lumen less than 5 mm and maintenance of a 
smooth intimal surface. 
2. Complex plaque is identified by extension more than 5 
mm from the aortic wall into the lumen, with disruption of 
intimal surface. 
Patient with complex atherosclerotic plague were found to have 
33% incidence of an embolic event in the month preceeding 
evaluation.  This is compared with an incidence of only 4% in 
group of control patient without aortic atherosclerosis evaluated by 
TEE.   
 
Tunick et al reported a case control study involving 122 patients 
referred for TEE evaluation of unexplained stroke and TIA and 
122 control patients.  The presence of protruding atheromas 
defined as lesion extending more than 5 mm into aortic lumen was 
found to strongly related to the occurrence of embolic symptoms. 
So many authors now recommend that complete TEE study 
for an unexplained source of embolism. 
 ISCHEMIC STROKE 
Stroke : 
 Defined as rapid onset of focal neurological deficit, resulting 
from diseases of the cerebral vasculature and its contents. 
 In India, community surveys have shown  a crude prevalence 
rate for stroke in the range of 200 per 1,00,000 persons, nearly 
1.5% of all urban hospital admissions, 4% of all medical and 
around 20% of neurological cases. 
Pathophysiology : 
 Except for lack of external elastic lamina in intracranial 
arteries the morphological structure of cerebral vessels in similar 
to other vascular bed.  The arterial wall consists of advertitia, 
media and intima.  The intima is a smooth monolayer of 
endothelial cells providing a non thrombotic surface to blood flow. 
 A cascade of complex biochemical events occurs seconds to 
mts after cerebral ischemia.  Ischemia causes impairment of brain 
energy metabolism, loss of aerobic glycolysis, intracellular 
accumulation of Sodium and calcium irons, elease of excitotoxic 
neurotransmitter elevation of lactatic level with local acidosis, free 
 radical production, cell swelling and cell death.  Many neurons 
undergo apoptosis after focal brain ischemia. 
 Complete interruption of flow causes suppression of 
electrical activity with 12 to 15 seconds, inhibition of synaptic 
excitability of control neurons after 4 mts and inhibition of 
electrical excitability after 4-6 mts. 
 Normal cerebral blood flow at rest in the normal adult brain 
is around 55 ml / 100 gm / mts. 
 First level occurs when blood flow decreases to 18ml / 100 
gm / mt, brain reaches a threshold for electrical failure.  At this 
level neurons have the potential for recovery.  Second level known 
as threshold of membrane failure, occurs when flow decreases to  
8 ml / 100 g / mt, cell death result. 
 
Classification of Ischemic Infarction : 
Pathological Classification : 
1. Bland Infarction 
2. Hemorrhagic Infarction 
 
 Bland Infarction : 
 When the cause is thrombus usually occlusion persists, 
preventing reperfusion of the region and resulting in pale, aremic 
or bland infarction. 
Hemorrhagic Infarction : 
 Occurs when varying amount of RBC’s found among the 
necrotic tissue.  The more intense the reperfusion and the more 
severly damaged the capillary walls, the more confluent the 
hemorrhagic infarction. 
Classification of Stroke : 
1. Infarct  -  70% 
2. Hemorrhage – 27% 
3. Others  - 3% 
70% Infarct : 
1. Undetermined cause - 28% 
2. Cardiac source  - 14% 
3. Lacune   - 19% 
4. Tandem arterial pathology - 4 % 
5. Large artery stenosis occlusion - 5% 
 CARDIOEMBOLIC STROKE  
 
 Cerebrovascular events are a serious complication of a 
diverse group of cardiac disorder.  Cardioembolic stroke are 
associated with substantial morbidity and mortality.  Embolism of 
cardiac origin is 15-20 % of all ischemic stroke. 
 Cardiac emboli composed of platelet, fibrin, platelet fibrin, 
calcium microorganisms or neoplastic fragments. 
 Cardiac source for thrombo embolism accounts for 20% of 
the embolic strokes.  Before the advent of Transesophageal Echo 
(TEE) various imaging modalities used for detection of cardiac 
source gave disappointed results.  TEE offers superior resolution 
of the left and right atrium and their appendages, inter-atrial 
septum, aorta, patent foramen ovale, atrial septal aneurysm, 
vegetations, and spontaneous echo contrast.  Thus TEE provides 
increased sensitivity for detection of various cardiac abnormalities 
associated with cardiac source of emboli.  Thromi and vegetative 
lesions associated with prosthetic or native cardiac valves are also 
visualized with a better resolution in TEE. 
 Etiology of cardiac source of thrombo embolism 
Definite : 
 Left atrial thrombus 
 Left ventricular thrombus 
 Tumor 
 Vegetation 
 Aortic debris 
Probable  
 Patent foramen ovale 
 Spontaneous echo contrast 
 Atrial septal aneurysm 
Possible  
 Valvular heart disease 
 Wall motion abnormality 
 Mitral valve prolapse 
TEE is useful in evaluation of cardiac source of embolism.  TEE 
identifies a potential cardiac source of embolism in approximately 
60% of the overall population compared with only 15% by 
Transthoracic Echocardiography TTE.  Even in patients without 
 clinical heart disease, TEE identifies abnormalities up to 39% of 
patients with cerebral ischemic events.  Pearson et al identified a 
potential source  for embolism in 57% of the study population with 
TEE when compared with the TTE, which identified only 15%.  
Both the techniques had a similar rate of identifying apical 
thrombus and mitral valve prolapse.  Overall TEE identified 
abnormalities in 39% of patients with no cardiac disease versus 
19% for transthoracic echocardiography. 
 
Left atrial thrombus : 
 The obvious advantage of TEE is the proximity of the left 
atrium to the transducer location in the esophagus.  In 
transthoracic Echocardiography the left atrium is frequently in the 
far field, in which attenuation of the ultrasound signal hampers the 
identification of thrombus.  Decisions regarding anticoagulation of 
patients, timing of cardioversion and assessment for percutaneous 
balloon mitral valvuloplasty are now more comprehensibly 
assessed with TEE.  The left atrial appendage is visualized at the 
basal level using anteflexion at o degree. 
  Gender Raugh et al found that TEE was superior to TTE for 
detection of a cardiac source of embolism in patients with acute 
ischemic stroke, 41% versus 5% factors associated with greater 
likelihood of such cardiac sources for embolism included left atrial 
enlargement, atrial fibrillation and a younger age. 
 The  sensitivity for detection of left atrial thrombi is 100 % 
specificity is 99% with the positive predictive value is 86% and 
negative predictive value is 100%.  TEE is accurate in detecting 
and excluding the left atrial thrombi. 
 
Left Ventricular thrombus : 
 TEE is useful in detection of LV thrombus.  In mid 
esophageal view LV is shortened.  This is overcome by the use of 
multiplane TEE.  The sensitivity and specificity of this technique 
is 80 to 90%.  By rotation of the transducer towards the LV help in 
identifying the apex.  Narrowing the sector using zoom option or 
switching to   frequency mode are also helpful.  Transgastric view 
will also be helpful in visualizing the apex using the probe 
unflexed.  If the transducer is rotated to 90, the apex has been in a 
 longitudinal orientation.  A deep trans gastric view is also used 
where the orientation is similar to the  trans thoracic view.  TEE is 
much helpful in identification, localization, and assessment of size, 
calcification, mobility and attachement to the ventricular wall. 
 
Tumor : 
 TEE is useful in identifying of atrial tumors like Myxoma 
and differentiation of Myxoma from atrial thromus.  Papilloma, 
Fibroma and Carcinoma are the most common source of emboli.  
Tumours may enter  atria via the inferior vena cava (hepatocellular 
cancer), via pulmonary veins (metastatic osteosarcoma, primary 
pulmonary malignancies).  The value of TEE is apparent in 
identification of these venous spreads, which cannot be identified 
by transthoracic echo. 
 
Infective Endocarditis : 
 Infective Endocarditis vegetations are identified with high 
accuracy by TEE.  The diagnostic yield  of two-dimensional 
echocardiography in identification of vegetations in patients with 
 documented endocarditis is approximately 60%, whereas the 
sensitivity of TEE in this regard is 90%.  TEE is useful in the 
demonstration of abscess formation in Infective Endocarditis.  The 
size, mobility and the rate of progress as assessed by TEE are 
important determinants of embolic potential. 
 
Aortic debris : 
 Protruding and mobile debris appear to have the highest 
embolic potential.  Large protrusive plaques have been identified 
both in the aortic arch and in the descending aorta in patients with 
unexplained embolic phenomenon by TEE. 
 
PFO and ASD : 
 Patent foramen ovale and atrial septal defects are known to 
occur in a significantly higher percentage of patients with cerebral 
ischemia.  Paradoxical emboli are responsible for the events.  TEE 
is superior when compared to TTE in evaluation of ASD.  With 
the injection of 10ml of agitated saline into an arm vein, the 
sensitivity and specificity of this technique is 100%.  Maneuvers to 
 increase the right atrial pressure such as cough or valsalva may be 
necessary to demonstrate shunting at patent foramen ovale.  It is 
also found in the majority of patients with atrial septal aneurysm 
and cerebral ischemia.  PFO is also independently associated with 
non-lacunar stroke especially in young patients. 
 
Spontaneous echo contrast : 
 Spontaneous echo contrast is a demonstration of smoke like 
swirling reflectance of intracardiac blood flow, most commonly 
seen in low flow states.  Most common clinical setting in which 
spontaneous echo contrast found is atrial fibrillation and mitral 
stenosis.  Spontaneous echo contrast is also seen in the left 
ventricle in patients with severe left ventricular dysfunction as 
well as in the right side of the heart.  The finding of spontaneous 
echo contrast, particularly in the left atrium has been shown to 
occur in a marker for blood stasis and subsequent thrombus 
formation.  This finding in patients with nonvalvular atrial 
fibrillation identifies a group of patients at high risk for subsequent 
embolic events. 
 Atrial septal aneurysm : 
 An atrial septal aneurysm is defined as a redundant interatrial 
septum usually located in the region of the fossa ovalis or 
sometimes involving the entire interatrial septum, which bulges 15 
mm or more beyond the plane of the atrial septum at some time 
during the cardiac cycle into either the right or the left atrium.  
This abnormality is reportedly found in only a small percentage of 
all transthoracic echocardiograms.  Case reports have identified 
patients particularly younger individuals, with cerebral ischemic 
events and no abnormalities other than atrial septal aneurysms.  In 
TEE, atrial septal aneurysm are identified in approximately 4% of 
all patients studied.  In patients with unexplained cerebral 
ischemia, however, it may be identified in up to 15% of this 
population.  These abnormalities provide a nidus for thrombus 
formation and blood stasis and therefore constitute a risk factor for 
cerebral embolization.  In patients with unexplained cerebral 
ischemia, atrial septal aneurysms are associated with atrial septal 
defects or patent foramen ovale in up to 75% of the cases.  There  
 
 is high rate of recurrent stroke or transient ischemic attack in 
patients with atrial septal aneurysm with or without shunt. 
 
 Most common cause in older individual is atrial fibrillation, 
accounting two thirds of emboli of cardiac origin.  Other cardiac 
conditions with high embolic potential include acute myocardial 
infarction, coronary artery disease with LV dysfunction, 
Rheumatic MS, Infective endocarditis, DCM, Cardiac tumours, 
mechanical prosthetic heart valves.  Low embolic risk disorders 
include PFO, ASA, Aortic thrombus, hypertropic cardiomyopathy, 
LV aneurysm, Mitral valve prolapse, Aortic valve calcification, 
calcific Aortic stenosis. 
 
 Let us consider about cause related to our study ie. Coronary 
artery disease with LV dysfunction Rheumatic MS with or without 
Atrial fibrillation, ASA, PFO, Aortic thrombus, hypertropic 
cardiomyopathy. 
 
 
 Coronary Artery Disease : 
 Almost all episodes of embolism occur within 3 months 
following Acute myocardial infarction, with 85% of emboli 
following first month.  A decreased ejection fraction is an 
independent predicator of an increased risk of stroke following 
myocardial infarction. 
 
Rheumatic Mitral Stenosis : 
 Most cases of mitral stenosis are caused by Rheumatic heart 
disease. Systemic embolic occurs in 10-15% of patients with 
mitral stenosis, with 60-75 % having cardioembolic cerebral 
ischemia. 
 
Atrial fibrillation : 
 Incidence of thrombo embolism in patient with AF is 4-8 %. 
Patients with nonvascular AF, leading source of cardioembolic 
infarction in older adults have a 6 fold increase in stroke 
incidence.  Patient with Rheumatic AF have 17 fold increase in 
stroke incidence. 
 Patent Foramen Ovale – PFO 
 Before birth, a channel exists between the two upper 
chambers of the heart.  This channel is called foramen ovale.  This 
allows oxygenated blood received from the mother to flow from 
the venous circulation to the arterial circulation.  Following birth, 
the lungs unfold and pressures in the circulatory system change, 
usually causing the channel to close.  However, in about 25% of 
people, this channel does not close.  In this case, the foramen ovale 
is said to remain patent.  People with this open channel are said to 
have a PFO. 
 
 Significance of finding a PFO in a patient with stroke remain 
unclear, although several studies have supported the notion that a 
high incidence of PFO exist in patient with cryptogenic stroke.  
Incidence of PFO is autopsy series has ranged from 13 to 35 %.  In 
a study comparing 60 adults with ischemic stroke under age 55 to 
100 normal control, PFO was prevalent in 40% of stroke patient 
versus only 10% of control.  Prevalence of PFO was even higher 
among those with no other identifiable cause of stroke. 
 Atrial septal Aneurysm -  ASA : 
 Out pouching of greater than 10-15 mm of the interatrial 
septum into either the left or right atrium.  Clinical relevance of 
ASA remain unclear, although it may possibly be associated with a 
high risk of cardioembolic stroke.  An association between ASA 
and stroke was found in another study  of 23 consecutive adult 
patient with ASA.  52% of the patient had suffered a 
throboemobolic cerebrovascular event. 
 
 Possible cause of stroke in ASA include embolism may 
occur secondary to paradoxical embolism of venous throbi, 
migration of a thrombus formed on the left side of the ASA or 
right sided thrombus farming on the ASA and embolizing through 
right to left shunt. 
 
Cryptogenic Infarction or Infarct of Undetermined cause : 
 Despite the large number of established source of emboli, the 
point of origin cannot be determined.  30% of Ischemic infarct 
group come under this category.   
 There are three main reasons for this, 
1. No appropriate laboratory studies are performed. 
2. Improper timing of the appropriate lab studies 
3. Normal findings are reached despite appropriate lab 
studies performed at appropriate time.  40% of the cause 
of ischemic stroke of undetermined cause fall in this 
category. 
 
Emerging technologies have led to the suggestion that some 
of the cyptogenic infarct cause may be explained by 
hematological disorder like hypercoaguable state.  Protein C, 
Free protein S, lupus anticoagulant or anticardiolipin antibody 
abnormalities.  Other have implicated paradoxical emboli 
through PFO or emboli from aorta and from ASA. 
 
 If extensive evaluation fails to disclose the origin, the odds 
still favour a source in left heart, not infrequently the diagnosis 
of cerebral is made at autopsy without finding a source.  
Nevertheless, in some cases, even when studied carefully  
postmortem, no source of embolic material can be discovered. 
 
  
 
MATERIALS AND METHODS 
 
Setting     : Inpatient of Government Rajaji Hospital,  
    Madurai 
 
Design of study : Observational study 
 
Period of study  : One year from October 2004. 
 
Sample Size and  
Selection of  
study subjects :      Fifty three CT Brain proved conscious  
ischemic stroke patients admitted in our 
department are included in this study.  This 
study included 31male and 22 female 
patients. 
 
 
 
 
 Details of Study Subjects : 
 All fifty three CT brain proved conscious ischemic stroke 
patients were underwent detailed history and physical 
examination.  History include fever, meningeal symptoms, weight 
loss, trauma, transient ischemic  attack, and joint swelling or pain 
and symptoms related to cardiac and respiratory conditions.  And 
any exposure to sexual transmitted disease or extramarietel 
contact. Whether he or she is a known case of diabetes, 
hypertension, pulmonary tuberculosis, congenital heart disease, 
Rheumatic heart disease, ischemic heart disease or cancer patient. 
 
 Physical examination include pulse rate, rhythm, character, 
felt in all palpable peripheral arteries, whether there is an thrill or 
bruit and blood pressure of both upper limb and lower limb. 
 
 All the subject had routine blood investigation like total 
count, differential count, hemoglobin level, renal function test and 
blood sugar level. 
  A 12 lead electrocardiogram is taken and transthoracic 
echocardiogram is also done for all patients. 
 All ischemic stroke patients of undetermined cause 
undergone rapid test HIV 1 and 2 and lipid profile. 
 
 Then atlast all patients underwent transesophageal 
echocardiography evalvation with multiplane capabilities using 
ALOKA SSD 2000 machine. 
 
Preparation of Patients before TEE : 
 Eight hours fasting is adviced.  Mild sedation before the 
procedure and an anesthetic agent is sprayed into the back of the 
throat in order to suppress the gag reflex.  Transesophageal 
echocardiographic examination generally last 15-20 mts.  A 
special viewing tube called an endoscope, containing a tiny 
transducer is passed through the mouth and into the esophagus.  It 
is carefully moved until it is positioned directly next to the heart.  
Essentially a modified microphone, the transducer directs 
ultrasound waves into the heart.  Some of which get reflected back 
 to the transducer.  Different tissue and blood all reflect ultrasound 
waves differently.  These sound waves can be translated into a 
meaningful image of the heart, which is displayed on a monitor or 
recorded on paper or tape. 
 
 The following characteristics were studied in all the groups.  
The left atrial appendage size, presence of left atrial thrombus, 
atrial septal aneurysm and patent foramen ovale were noted for 
contrast study was done in all the patients by injecting agitated 
saline through right upper limb peripheral vein.  The presence of 
even a single bubble in the left atrium within the first 3 to 5 
cardiac cycles was taken as an evidence for the presence of right 
and left shunting across the patent foramen ovale.  The inter atrial 
septum was imaged in atleast 3 views, long axis plane, short axis 
plane, and the bi-cameral view. 
 
 Presence of interatrial septal excursions were also 
interrogated to rule out atrial.  Septal aneurysm.  A definite atrial 
septal aneurysm  was diagnosed when there was atleast 1.1 cm 
 excursion into either left atrium or right atrium with a base of 
atleast 1.5 cm. 
 
 All the patients underwent imaging of the ascending, arch 
and descending aorta for the presence of atheromas, mobile 
masses protruding into the lumen. 
 
After care : 
 After the test, it is important to refrain from eating or 
drinking until the gag reflex has returned otherwise the patient 
may accidentally inhale some of the food or beverage. 
 
 
 
 
 
 
 
 
 RESULTS  
 Among 53 ischemic stroke patients 11 had Rheumatic mitral 
stenosis with and without atrial fibrillation, 7 were female and 
mean age in the group was 30.1 + 6.2 years and 11 were 
categorized as cryptogenic ischemic stroke patient (without TEE)  
and 31 were categorized as other causes ie. having risk factors like 
diabetes, hypertension, ischemic heart disease and hypertropic 
cardiomyopathy. 
 Among the Rheumatic mitral stenosis patients 4 had atrial 
fibrillation and 6 had left atrial thrombus 
 Among the other causes patients, 5 were known case of 
diabetes, 18 were known case of hypertension and diabetes, 2 were 
known case of ischemic heart disease and 1 was hypertropic 
cardiomyopathy. 
 Percentage of ischemic stroke patients with risk factors like 
diabetes, hypertension, Rheumatic heart disease, ischemic heart 
disease with LV dysfunction and hypertrophic cardiomyopathy 
was 79.3%. 
 Percentage of ischemic stroke due to Rheumatic heart 
disease with and without Atrial Fibrillation was 20.7%. 
 Percentage of ischemic stroke due to hypertension was 9.4%. 
 Percentage of ischemic stroke due to diabetes was 9.4 % 
Percentage of ischemic stroke due to hypertension and 
diabetes was 34%. 
 
Specific to our study : 
 Percentage of atrial septal aneurysm in our study was 7.5% 
 Percentage of Aortic thrombus in our study was 5.6 % 
 Percentage of patent foramen ovale in our study was 3.7 % 
Percentage of Atrial septal aneurysm among  
cryptogenic stroke patient 36.4% 
 Percentage of Aortic thrombus among cryptogenic stroke 
 patient was 27.3 % 
 Percentage of patent foramen ovalve among cryptogenic  
  stroke patient was 18.2 % 
 
 
  In cryptogenic stroke patient rheumatic heart disease, 
diabetes, hypertension and ischemic heart disease were ruled out. 
 All cryptogenic stroke patient were under 50 years, mean age 
38.5 years. 
 None of the patient was smoker or alcoholic.  In all 
cryptogenic stroke patients lipid profile was normal and rapid test 
HIV was negative. 
 Among the previously diagnosed as 11 cryptogenic stroke 
patients,  9 patients the cause was identified by TEE.  ( 4 had atrial 
septal aneurysm, 3 had aortic thrombus and 2 had patent foramen 
ovale).  In 2 patients the cause was undetermined.  So these 
patients should undergo further investigations like coagulation 
profile. 
 But transthoracic echocardiography was normal in the 11 
patients. 
 Therefore percentage of ischemic stroke of undetermined 
cause without TEE – 20.7% and percentage of ischemic stroke of 
undetermined cause TEE was 3.7 % only. 
 
  
 Therefore in the  so called cryptogenic ischemic stroke 9 of 
the 11 patients had positive finding in TEE which were not picked 
up by transthoracic echocardiography. 
 
 Therefore, Transesophageal echocardiography play an 
important role in identifying the cause in patients who were 
previously diagnosed as cryptogenic ischemic stroke patients. 
 
 
 
 
 
 
 
 
 
 
 
 DISCUSSION 
 
 In 1984, Hagen et al reported about 27%. Prevalence of atrial 
septal malformation in an autopsy series of 965 hearts believed to 
be normal.  The prevalence of septal abnormalities declined from 
34% during the first 3 decades of life to 20% in the ninth decade 
of life.6 
 Lynch et al performed contrast echo evaluation in 100 
patients with no history of stroke and 60 patients with ischemic 
stroke and found a 10%. Prevalence of PFO in the control group 
and as high as 40% in the stroke patients. 7 
 Pearson et al established the superiority of Transesophageal 
echocardiography over transthoracic echocardiography in 79 
patients of unexplained stroke, where only 15% had potential 
cardiac source of embolism in transthoracic echocardiography but 
about 57% had some of evidence of cardiac source when 
examined with transesophageal esophageal echocardiography.9  
The abnormalities detected were atrial septal aneurysm with patent 
 foramen ovale, left atrial appendage thrombus and left atrial 
spontaneous  echo contrast. 
 Pearson et al in yet another study found that atrial septal 
aneurysm was diagnosed more frequently in patients with stroke 
15% vs 4% (normal). 9,28 
 In multiple studies by Karalis et al10, Katz et al11, Tunick et 
al12, Vaduganathan13, there was a positive correlation of the 
presence of aortic atheromo with stroke. 
 Di Pausquale in his studied showed atrial septal aneurysm a 
potential cause of cardioembolic stroke. 29 
 Hausmann et al , mugge et al, study compares the value of 
transthoracic and transesophageal contrast echo cardiography for 
detecting a patent foramen ovale.  A total of 238 patients were 
studied.  74 patients with a history of otherwise unexplained 
ischemic stroke or transient cerebral ischemic attack (Group A); 
48 with a history of similar episodes explained by other cardiac 
abnormalities (group B) and 116 with no embolic events        
(group c)24,27 
  TEE play an important role in diagnosing atrial septal 
aneurysm was showed in two studies.30,31 
A PFO was detected by contrast transesophageal 
echocardiography in 50 of 238 patients compared with 45 patients 
by transthoracic. In a subgroup of 198 patients, tranesophageal 
echocardiography results could be compared with transthoracic 
echocardiography findings. Contrast transthoracic echo 
cardiography detected a PFO in 15 patients compared with 
contrast transesophageal echocardiography which demonstrated a 
PFO in 44 of 198 patients.   
 Prevalence of PFO of TEE was 22, 21 and 22% in groups 
A,B and C respectively. Thus, contrast transophageal 
echocardiography are significantly superior to transthoracic 
echocardiography for detected patient foramen ovale.  Prevalence 
of PFO is significantly increased in young adults with otherwise 
unexplained ischemic stroke. 
 In our study also we found high percentage of patients with 
inter atrial septal abnormalities like atrial septal aneurysm and 
patent foramen ovals, plaques in the aorta were also present in 
 quite good number of patient in the so called cryptogenic ischemic 
stroke group. 
 Cabanes et al found in his study that among cryptogenic 
ischemic stroke patients 39% had atrial septal aneurysm which 
was similar in our study 36.4%.  However the percentage of patent 
foramen ovale was much higher in their study group 56.3%. 
Unlike in our study 18.2%14 
 Mowla Ashkan et al in his study of 98 patients with ischemic 
stroke found out abnormalities in 94.8% of patients.  Using 
transesophageal echocardiography.  But in our study of 53 
ischemic stroke patients we found abnormal transesophageal 
echocardiography in the form of valvular pathology, atrial septal 
aneurysm, patent foramen ovale and aortic atherumas in about 20 
patients. 37.7%.15 
 Bruno censori found in his study that an early TEE doesnot 
seem to increase substantially the detection of atrial thrombi or 
spontaneous ECHO contrast in patients with a first stroke attack of 
cryptogenic or Lacunar nature.  Therefore, this examination can be 
 carried out when the patient conditions are stable and without 
overloading the cardiovascular laboratory daily schedule.26  
 Nishide showed in his study the most common cardiac 
abnormalities in ischemic stroke studied by two-dimensional 
echocardiography.32 
 Shyu pointed out the role of TEE in the diagnostic 
assessment of cardiac sources of embolism in patients with acute 
ischemic stroke. 33 
Andreas Mugge found in his study that TEE is superior to 
TTE approach in the diagnosis of ASA.  The most common 
abnormalities associated with ASA are interatrial shunts in 
particular patent foramen ovale.  In this study, patient with ASA 
showed a high frequency of previous clinical events compatiable 
with cardiogenic embolism, in a significant subgroup of patients, 
ASA appears to be the only source of embolism, as judged by 
TEE.  Our data are consistent with the view that ASA is a risk 
factor for cardiogenic embolism, but thrombi attached to ASA as 
detected by TEE are apparently rare. 25 
 
 However the diagnostic yield of transesophageal 
echocardiography in patients with ischemic stroke of no known 
cause that is cryptogenic ischemic stroke was high as 81.8% (9 out 
of 11 patients) in our study. 
 To conclude, we recommend the routine use of 
transesophageal echocardiography in patients with ischemic stroke 
to find out the possible cardiac source of embolism with special 
emphasis in patients with no other possible or probable cause of 
ischemic stroke, cryptogenic stroke. 
Limitation of the Study : 
 Because of the financial constraints in the institution and 
poor socio economic status of patients in our study population, 
exhaustive workup of the coagulation profile was not done. 
 Similarly carotid Doppler and intimal thickness measurement 
were not routinely done in these patients. 
 Eventhough the mean age of the study group in cryptogenic 
ischemic stroke was 38.5 years and carotid abnormalities are not 
routinely expected in this age group, it however is a limitation in 
our study. 
  
 
 
 
  CONCLUSION 
 
 To conclude, transesophageal echocardiography evaluation 
should be an integral part in diagnostic workup of patients with 
cryptogenic stroke.  Our study showed atrial septal aneurysm, 
positive contrast study and aortic thrombus in 9 out of 11 number 
of patients. 
 
 
 
 
 
 
 
 SUMMARY 
 
 Among 53 concious ischemic stroke patients 11 had 
Rheumatic mitral stenosis with and without atrial fibrillation and 
left atrial thrombus, 11 were categorized as cryptogenic ischemic 
stroke patients and 31 were categorized as other causes patients. 
 
 All cryptogenic stroke patients were  under 50 years, mean 
age was 38.5 years, None of the patient was smoker or alcoholic.  
In all cryptogenic patients lipid profile was normal and rapid test 
HIV was negative.  Among the previously diagnosed as 11 
cryptogenic stroke patients, 9 patients the cause was identified by 
TEE.  In 2 patients the cause was undermined, so these patients 
should undergo further investigations like coagulation profile. 
 
 Therefore transesophageal echocardiography play an 
important role in identifying the cause in patients who were 
previously diagnosed as cryptogenic ischemic stroke patients. 
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 PROFORMA 
TRANSESOPHAGEAL ECHOCARDIOGRAPHY STUDY IN 
CRYPTOGENIC ISCHEMIC STROKE 
 
Name  :     Age  :  Sex : 
History : Fever, Meningeal symptoms, weight loss, trauma, 
transient ischemic attack, joint swelling or pain symptoms related to 
cardiac and respiratory conditions. 
Diagnosis  : 
CT Scan : 
HT  :     Diabetes : 
Rheumatic Heart Disease :   
TIA  : 
Pulse rate : 
Systolic BP :     Diastolic BP  : 
Murmur  : 
Random blood sugar  :   Urea  : 
Creatinine : 
ECG  :     TTE   : 
Inter atrial septum  : 
Contrast TEE study : 
Left atrial appendage :   Descending Aorta : 
Atheroma :     Left atrial clot       : 
 MASTER CHART 
S.No. Name Age Sex Diagnosis CT Scan HT DM RHP TIA PR SBP DBD 
1.  Pappathy 46 F L.Hemiplegia RMCA + + - - 104 150 100 
2.  Pandiammal 35 F R.Hemiplegia LMCA - - + - 106 130 100 
3.  Mangayarkani 24 F L.Hemiplegia RMCA + - - - 80 140 90 
4.  Veerammal 40 F L.Hemiplegia RMCA - - - - 76 130 90 
5.  Karuppasamy 35 M R.Hemiplegia LMCA + + - - 90 140 100 
6.  Poomari 36 F R.Hemiplegia LMCA - - - - 100 130 90 
7.  Gomathiammal 65 F R.Hemiplegia LMCA + + - - 76 140 90 
8.  Anantha jothi 33 F R.Hemiplegia LMCA + - - - 80 130 90 
9.  Parthasarathy 65 M R.Hemiplegia LMCA - - - - 80 140 90 
10. Vedamoorthy 50 M L.Hemiplegia RMCA - + - - 82 140 90 
11. Immanuel 24 M L.Hemiplegia RMCA - - - - 90 130 90 
12. Rajendran 40 M L.Hemiplegia RMCA + - - - 90 140 90 
13. Paulraj 45 M R.Hemiplegia LMCA - - - - 84 150 100 
14. Chandrasekar 56 M L.Hemiplegia RMCA + + - - 90 130 80 
 15. Marimeena 61 F R.Hemiplegia LMCA + + - - 90 120 80 
16. Masanam 48 M R.Hemiplegia LMCA - - - - 80 130 90 
17. Boominathan  70 M L.Hemiplegia RLMCA + - - - 90 130 90 
18. Samraj 38 M L.Hemiplegia RMCA - - - - 76 146 100 
19. Gurusamy 47 M R.Hemiplegia LMCA + + - - 86 134 90 
20. Veerathevar 57 M R.Hemiplegia LMCA - + - - 90 130 90 
21. Mayan 59 M R.Hemiplegia LMCA - + - - 92 140 90 
22. Vasanthakumari 29 F R.Hemiplegia LMCA - - + - 100 140 80 
23. Roshanbeevi 70 F L.Hemiplegia RMCA + + - - 76 130 80 
24. Meenalochani 60 F R.Hemiplegia LMCA + - - - 80 140 90 
25. Ammapillai 32 M L.Hemiplegia RMCA - - + - 86 120 90 
26. Uma rani 36 F L.Hemiplegia RMCA - - - - 80 110 70 
27. Amaravathy 30 F L.Hemiplegia RMCA - - + - 90 130 90 
28. Pandi 40 M L.Hemiplegia RMCA - + - - 80 120 90 
29. Sagundala 60 F R.Hemiplegia LMCA + + - - 86 120 80 
30. Vellammal 39 F R.Hemiplegia LMCA - - - - 92 130 80 
31. Alagar 40 M L.Hemiplegia RMCA - - + - 82 130 80 
 32. Sankarammal 34 F L.Hemiplegia RMCA - - + - 72 140 96 
33. Gomathy 56 F R.Hemiplegia LMCA + + - - 76 140 90 
34. Gulam 52 M L.Hemiplegia RMCA + + - - 90 130 90 
35. Vedamuthu 70 M R.Hemiplegia LMCA + + - - 90 150 90 
36. Pathapriya 22 F R.Hemiplegia LMCA - - + - 76 140 80 
37. Murugesan 62 M R.Hemiplegia LMCA + + - - 86 130 90 
38. Ammavasai 57 M L.Hemiplegia RMCA + + - - 80 140 90 
39. Pappammal 54 F L.Hemiplegia RMCA + + - - 86 120 80 
40. Sasikumar 40 M R.Hemiplegia LMCA + + - - 920 130 80 
41. Muthu 40 M L.Hemiplegia RMCA - - - - 92 140 70 
42. Sundran 40 M L.Hemiplegia RMCA - - - - 76 145 76 
43. Radha 62 F L.Hemiplegia RMCA - - - - 86 136 80 
44. Raja 46 M L.Hemiplegia RMCA - - - - 86 130 90 
45. Balan 27 M L.Hemiplegia RMCA + + - - 80 126 80 
46. Vasu 40 M R.Hemiplegia LMCA - - - - 70 130 90 
47. Malliga 28 F L.Hemiplegia RMCA - - + - 110 100 70 
48. Jansi 33 F R.Hemiplegia LMCA - - + - 106 110 80 
 49. Nuthan 24 M L.Hemiplegia RMCA - - + - 120 120 70 
50. Rajendran 30 M R.Hemiplegia LMCA - - + - 110 100 70 
51. Madasamy 55 M R.Hemiplegia LMCA + + - - 90 130 100 
52. Kannan 63 M L.Hemiplegia RMCA + + - - 90 126 96 
53. Arjun 40 M L.Hemiplegia RMCA - - - - 80 130 96 
 
 
 
 
 
 
 
 
  
S.No. Sugar Urea Crea 
tinine 
ECG TTE IAS Bubble 
study 
LAA Des. 
Aorta 
Atheroma LA 
Clot 
1. 120 50 0.7 SR/WNL N I - 2.2x1.9 2x1.9 - - 
2 75 24 1 SR/WNL MS severe I - 3.9x2.2 1.9x1.2 - - 
3 79 50 1 SR/WNL N I - 2.5x1.3 1.7x1.2 - - 
4 140 32 0.6 SR/WNL N ASA - 2.0x1.7 1.8x1.0 - - 
5 102 25 0.9 SR/WNL N I - 1.7x2.8 2.2x1.2 - - 
6 102 29 1 SR/WNL N I + 3.3x1.6 1.8x1.1 - - 
7 202 30 1 SR/WNL N I - 2.2x1.8 2.3x1.2 - - 
8 136 30 0.8 SR/WNL N I - 2.0x1.3 1.8x1.0 - - 
9 120 30 0.9 SR/WNL N I - 2.1x1.3 1.8x1.1 - - 
10 126 30 0.7 SR/WNL N I - 2.2x1.2 1.3x1.1 - - 
11 120 30 0.7 SR/WNL N I - 2.0x1.3 2.0x1.2 - - 
12 130 35 1 SR/WNL N I - 2.3x1.3 1.7x1.2 - - 
13 106 25 0.7 SR/WNL N ASA - 2.0x1.2 2.3x1.2 - - 
14 206 30 0.8 SR/WNL N I - 2.4x1.3 2.1x1.2 - - 
 15 
 
140 40 1 SR/WNL N I - 2.7x1.2 1.9x1.2 - - 
16 120 36 1 SR/AWMI RWMA Moderate 
LV dysfunction I - 2.6x1.1 1.9x1.2 - - 
17 118 32 0.7 SR/WNL N I - 2.2x1.9 2.1x1.2 - - 
18 127 35 0.8 SR/WNL N I - 2.3x1.9 2.2x1.6 - - 
19 212 30 1 SR/WNL N I - 2.3x1.2 2.4x1.5 - - 
20 106 28 0.7 SR/WNL N I - 3.1x1.1 2.6x1.7 - - 
21 200 25 1 SR/WNL N I - 2.6x1.2 2.7x1.6 - - 
22 106 30 0.6 SR/LAE MS Severe I - 2.7x1.1 3.1x1.6 - - 
23 163 32 0.7 SR/WNL N I - 2.7x1.6 2.6x1.2 - - 
24 112 26 0.8 SR/WNL N I - 3.1x1.6 2.7x1.6 - - 
25 160 25 1.1 SR/LAE MS Severe MR 
Grade II 
I - 2.6x1.2 2.5x1.7 - - 
26 120 40 1 SR/WNL N I - 2.7x1.7 2.1x2.0 - - 
27 120 30 0.7 SR/LAE MS Severe I - 2.6x1.6 2.2x1.6 - - 
28 140 31 0.7 SR/WNL N I - 3.1x1.6 2.1x1.2 - - 
29 155 30 0.6 SR/WNL N I - 3.0x1.5 2.1x1.3 - - 
30 150 40 0.8 SR/WNL N ASA - 2.9x1.6 2.2x1.6 - - 
31 120 41 1 SR/LAE MS Severe I - 2.8x1.6 1.9x1.1 - - 
 32 120 40 1 SR/LAE MS Severe I - 2.7x1.2 2.1x1.6 - - 
33 140 30 0.8 SR/WNL N I - 3.0x1.6 2.2x1.6 - - 
34 155 30 0.7 SR/WNL N I - 2.6x1.6 2.3x1.4 - - 
35 160 30 1 SR/WNL N I - 2.9x1.6 2.0x1.6 - - 
36 125 40 0.7 SR/LAE MS Severe I - 2.6x1.3 2.0x1.2 - - 
37 162 35 0.6 SR/WNL N I - 2.4x1.2 2.0x1.2 - - 
38 152 32 1 SR/WNL N I - 2.2x1.6 2.2x1.6 - - 
39 168 40 0.8 SR/WNL N I - 2.1x1.4 2.1x1.2 - - 
40 129 40 0.7 SR/WNL N I - 2.2x1.6 2.2x1.2 - - 
41 168 30 0.8 SR/WNL N I - 2.2x1.4 2.1x1.2 - - 
42 120 25 0.9 SR/AWM1 RWMA / 
Moderate LV 
dysfunction 
I - 2.3x1.4 2.1x1.1 - - 
43 118 30 1 SR/LVH ASH/SAM LVOT 
GV 63 TR 26MM 
Hg 
I - 2.3x1.2 2.1x1.1 - - 
44 175 35 0.7 LVH LVH I - 3.8x1.1 2.5x2.0 - - 
45 160 36 0.6 SR/WNL N I - 3.6x1.0 2.4x1.6 - - 
46 120 25 0.7 SR/WNL N I + 3.7x1.2 2.5x1.6 - - 
47 120 38 0.8 AF / CVR MS Severe I - 3.8x2.2 2.6x1.4 - - 
48 160 40 1 AF / CVR MS Severe I - 3.6x2.0 2.5x1.6 - - 
 49 175 42 0.7 AF / CVR MS Severe I - 3.6x2.2 2.2x1.2 - - 
50 170 30 0.6 AF / CVR MS Severe I - 3.6x1.6 2.6x1.0 - - 
51 170 40 1 SR / LVH N I - 2.5x1.2 2.6x1.6 - - 
52 160 35 1.1 SR / LVH N I - 2.5x1.1 2.2x1.4 - - 
53 120 30 0.6 SR / LVH N I - 2.4x1.6 2.1x1.2 - - 
 
 
 
 
 
